Clinical Trial Update: Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of Folatescan (Technetium TC 99M EC20) in patients with suspected ovarian carcinoma or recurrent endom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Carcinoma
• Ovarian Carcinoma

Drugs mentioned

• FolateScan

Snippet

Sponsor: Endocyte | Conditions: Ovarian Carcinoma, Recurrent Endometrial Carcinoma | Phase 2 | Status: COMPLETED